RRSP04 The state of Life Sciences, pt 4 - The future of health and better patient outcomes with Thorsten Rall, Capgemini

Life sciences are at a turning point, where scientific innovation, regulatory pressure, and patient expectations collide with unprecedented advances in data, AI, and digital platforms. IT is no longer a supporting function but a critical driver of how therapies are discovered, developed, scaled, and delivered safely and at speed.

This week, Dave and Rob wrap up our State of Life Sciences mini-series with Thorsten Rall, Global Industry Lead for Life Sciences at Capgemini and together, they connect the dots across the series, exploring how AI, data and innovation are accelerating drug discovery, transforming med tech, modernising manufacturing and improving patient outcomes, all built on a strong digital foundation.

TLDR

00:27 – Introduction and conclusion of the Life Sciences mini-series

02:16 – Key insights and lessons from the previous episodes on the Life Sciences landscape

21:18 – Building resilient, efficient and future-ready operations

34:35 – Creating integrated, patient-centric healthcare experiences

43:15 – Why the Digital Core is the foundation for transformation and innovation

53:21 – Final reflections: the future of Life Sciences and the key takeaways

54:53 – Weekend BBQs, Thorsten's daughter's theatre performance, and the role of R&D

Hosts

Dave Chapman:  https://www.linkedin.com/in/chapmandr/